Cargando…

The Serum Metabolomics Study of Liver Failure and Artificial Liver Therapy Intervention

BACKGROUND: This study was designed to study the serum metabolites of patients with liver failure. MATERIAL/METHODS: The study included 50 patients with liver failure, 30 patients with chronic hepatitis B treated with an artificial liver, 11 patients with an artificial liver, and 32 healthy controls...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Shipeng, Hu, Dali, Yuan, Songsong, He, Ying, Li, Chengmu, Zhu, Ying, Wu, Xiaoping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Scientific Literature, Inc. 2021
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8525311/ https://www.ncbi.nlm.nih.gov/pubmed/34650025 http://dx.doi.org/10.12659/MSM.930638

Ejemplares similares

Serum Metabonomics Analysis of Liver Failure Treated by Nonbioartificial Liver Support Systems
por: Wu, Chunyan, et al.
Publicado: (2018)

Artificial liver support in pigs with acetaminophen-induced acute liver failure
por: He, Guo-Lin, et al.
Publicado: (2017)

Higher serum uric acid to HDL-cholesterol ratio is associated with onset of non-alcoholic fatty liver disease in a non-obese Chinese population with normal blood lipid levels
por: Zhu, Wentao, et al.
Publicado: (2022)

Serum Metabolomic Analysis of Chronic Drug-Induced Liver Injury With or Without Cirrhosis
por: Chen, Shuai-shuai, et al.
Publicado: (2021)

Serum Liver Fibrosis Markers in the Prognosis of Liver Cirrhosis: A Prospective Observational Study
por: Qi, Xingshun, et al.
Publicado: (2016)

Efficacy and Economic Evaluation of Nonbiological Artificial Liver Therapy in Acute-on-chronic Hepatitis B Liver Failure
por: Wu, Cichun, et al.
Publicado: (2023)

Artificial liver support system therapy in acute-on-chronic hepatitis B liver failure: Classification and regression tree analysis
por: Huang, Kaizhou, et al.
Publicado: (2019)

Urinary metabolomics analysis identifies key biomarkers of different stages of nonalcoholic fatty liver disease
por: Dong, Shu, et al.
Publicado: (2017)

Metabolomics Differences of the Donor Livers Between In Situ and Ex Situ Conditions During Ischemia-free Liver Transplantation
por: Guo, Zhiyong, et al.
Publicado: (2023)

Serum Metabolic Disturbances Associated with Acute-on-chronic Liver Failure in Patients with Underlying Alcoholic Liver Diseases: An Elaborative NMR-based Metabolomics Study
por: Kumar, Umesh, et al.
Publicado: (2021)

Artificial Liver Support System Combined with Liver Transplantation in the Treatment of Patients with Acute-on-Chronic Liver Failure
por: Xu, Xiao, et al.
Publicado: (2013)

Elevation of Serum Cytokine Profiles and Liver Metabolomic Normalization in Early Convalescence of COVID-19 Patients
por: Lou, Yan, et al.
Publicado: (2021)

Serum Metabolomics to Identify the Liver Disease-Specific Biomarkers for the Progression of Hepatitis to Hepatocellular Carcinoma
por: Gao, Rong, et al.
Publicado: (2015)

Explorative study of serum biomarkers of liver failure after liver resection
por: Yoon, Kyung Chul, et al.
Publicado: (2020)

Clinical observation on the treatment of acute liver failure by combined non-biological artificial liver
por: Li, Maoqin, et al.
Publicado: (2016)

Clinical Study of Serum Homocysteine and Non-Alcoholic Fatty Liver Disease in Euglycemic Patients
por: Hu, Yanjin, et al.
Publicado: (2016)

Application of embolization microspheres in interventional therapy of malignant non-hypervascular tumor of liver
por: Niu, Huanzhang, et al.
Publicado: (2017)

The combination of serum oligosaccharide chain (G-test), alpha-fetoprotein, and aspartate aminotransferase to alanine aminotransferase ratio provides the optimal diagnostic value for early detection of hepatocellular carcinoma
por: Zhu, Wentao, et al.
Publicado: (2022)

Retraction: Artificial Liver Support System Combined with Liver Transplantation in the Treatment of Patients with Acute-on-Chronic Liver Failure
Publicado: (2019)

Efficacy of Fluidized Bed Bioartificial Liver in Treating Fulminant Hepatic Failure in Pigs: A Metabolomics Study
por: Zhou, Pengcheng, et al.
Publicado: (2016)

Heparin-like effect contributes to the coagulopathy in patients with acute liver failure undergoing liver transplantation
por: Senzolo, Marco, et al.
Publicado: (2009)

Analysis of Risk Factors and Protective Strategies for Tube Blockage in Patients with Drug-Induced Liver Failure Based on Artificial Liver Therapy
por: Shen, Yan, et al.
Publicado: (2023)

Single-center experience in 127 adult patients, mono or dual artificial liver support therapy, in patients with acute liver failure
por: Ocak, Ilhan
Publicado: (2023)

Prometheus® liver therapy in children with acute liver failure
por: Walle, J Vande, et al.
Publicado: (2015)

Avicularin alleviates acute liver failure by regulation of the TLR4/MyD88/NF‐κB and Nrf2/HO‐1/GPX4 pathways to reduce inflammation and ferroptosis
por: Shi, Pei, et al.
Publicado: (2023)

A practical nomogram based on serum interleukin-6 for the prognosis of liver failure
por: Xiao, Nanxi, et al.
Publicado: (2022)

Characteristics of circulating immune cells in HBV-related acute-on-chronic liver failure following artificial liver treatment
por: Ju, Tao, et al.
Publicado: (2023)

Economic evaluation of the artificial liver support system MARS in patients with acute-on-chronic liver failure
por: Hessel, Franz P
Publicado: (2006)

Association of duration and etiology with the effect of the artificial liver support system in pediatric acute liver failure
por: Yang, Chun-Feng, et al.
Publicado: (2022)

Protective Effect of Probiotics against Esophagogastric Variceal Rebleeding in Patients with Liver Cirrhosis after Endoscopic Therapy
por: Zhang, Qun, et al.
Publicado: (2020)

Acute liver failure secondary to toxic exposure in children
por: Grama, Alina, et al.
Publicado: (2019)

Preoperation risk factor analysis in orthotopic liver transplantation with pretransplant artificial liver support therapy
por: Ye, Q, et al.
Publicado: (2004)

Efficacy of Sorafenib Combined with Interventional Therapy on Primary Liver Cancer Patients and Its Effect on Serum AFP, VEGF, and GGT
por: Jia, Ying, et al.
Publicado: (2021)

Serum metabolomic analysis of the effect of exercise on nonalcoholic fatty liver disease
por: Li, Jia, et al.
Publicado: (2019)

Serum metabolome alterations in patients with early nonalcoholic fatty liver disease
por: Wang, Xuemei, et al.
Publicado: (2022)

Short-Term Stability of Serum and Liver Extracts for Untargeted Metabolomics and Lipidomics
por: Hricko, Jiri, et al.
Publicado: (2023)

Serum Markers of Iron Metabolism in Chronic Liver Diseases
por: Radicheva, Mariana Penkova, et al.
Publicado: (2018)

Caveolin-1 Alleviates Acetaminophen-Induced Fat Accumulation in Non-Alcoholic Fatty Liver Disease by Enhancing Hepatic Antioxidant Ability via Activating AMPK Pathway
por: Wang, Jiarong, et al.
Publicado: (2021)

Acute-on-chronic liver failure: an update
por: Hernaez, Ruben, et al.
Publicado: (2017)

The Microbiome in Autoimmune Liver Diseases: Metagenomic and Metabolomic Changes
por: Zheng, Yanping, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_aol245tnjrkj8gcqphqe24iaea